CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea
Seungjoon Oh, Suk Chon, Kyu Jeong Ahn, In-Kyung Jeong, Byung-Joon Kim, Jun Goo Kang
Diabetes Metab J. 2015;39(3):177-187.   Published online June 15, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.3.177

Excel Download

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea
Diabetes & Metabolism Journal. 2015;39(3):177   Crossref logo
Link1 Link2 Link3

Reshaping Diabetes Care: The Fundamental Role of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Clinical Practice
Endocrine Practice. 2013;19(4):718-728   Crossref logo
Link1 Link2 Link3

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
Diabetes Spectrum. 2017;30(3):202-210   Crossref logo
Link1 Link2

Glucagon-Like Peptide 1 Receptor Agonists For Type 2 Diabetes: A Comprehensive Review of How to Weigh The Options, Select the Right Patients, and Maximize Benefits
Endocrine Practice. 2018;24:8-19   Crossref logo
Link1 Link2

Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists
Clinical Therapeutics. 2017;39(6):1244-1264   Crossref logo
Link1 Link2

Efficacy and safety of high‐dose glucagon‐like peptide‐1, glucagon‐like peptide‐1/glucose‐dependent insulinotropic peptide, and glucagon‐like peptide‐1/glucagon receptor agonists in type 2 diabetes
Diabetes, Obesity and Metabolism. 2022;24(5):788-805   Crossref logo
Link1 Link2 Link3

Glucagon-like peptide 1 receptor agonists and cardiovascular risk in type 2 diabetes: a clinical perspective
Diabetes, Obesity and Metabolism. 2014;17(4):335-342   Crossref logo
Link1 Link2

Glucagon-like peptide-1 receptor agonists
Handbook of Incretin-based Therapies in Type 2 Diabetes. 2016;31-43   Crossref logo
Link1

Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: An integrative review
Diabetes Research and Clinical Practice. 2019;149:78-88   Crossref logo
Link1 Link2

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
International Journal of Clinical Practice. 2009;63(8):1154-1160   Crossref logo
Link1 Link2